Screener
AOCI at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The source filing: Boston Scientific’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 6:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885725-26-000033
FAQ
- What is Boston Scientific's AOCI?
- Boston Scientific (BSX) reported AOCI of -$398M in Q1 2026.
- How has Boston Scientific's AOCI changed year-over-year?
- Boston Scientific's AOCI decreased by 1321.4% year-over-year, from -$28M to -$398M.
- What is the long-term trend for Boston Scientific's AOCI?
- Over 5 years (2020 to 2025), Boston Scientific's AOCI has grown at a 24.1% compound annual growth rate (CAGR), from $207M to -$610M.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.
Ask your AI about Boston Scientific's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude